Cargando…
Machine Learning and Radiogenomics: Lessons Learned and Future Directions
Due to the rapid increase in the availability of patient data, there is significant interest in precision medicine that could facilitate the development of a personalized treatment plan for each patient on an individual basis. Radiation oncology is particularly suited for predictive machine learning...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6021505/ https://www.ncbi.nlm.nih.gov/pubmed/29977864 http://dx.doi.org/10.3389/fonc.2018.00228 |
_version_ | 1783335487134498816 |
---|---|
author | Kang, John Rancati, Tiziana Lee, Sangkyu Oh, Jung Hun Kerns, Sarah L. Scott, Jacob G. Schwartz, Russell Kim, Seyoung Rosenstein, Barry S. |
author_facet | Kang, John Rancati, Tiziana Lee, Sangkyu Oh, Jung Hun Kerns, Sarah L. Scott, Jacob G. Schwartz, Russell Kim, Seyoung Rosenstein, Barry S. |
author_sort | Kang, John |
collection | PubMed |
description | Due to the rapid increase in the availability of patient data, there is significant interest in precision medicine that could facilitate the development of a personalized treatment plan for each patient on an individual basis. Radiation oncology is particularly suited for predictive machine learning (ML) models due to the enormous amount of diagnostic data used as input and therapeutic data generated as output. An emerging field in precision radiation oncology that can take advantage of ML approaches is radiogenomics, which is the study of the impact of genomic variations on the sensitivity of normal and tumor tissue to radiation. Currently, patients undergoing radiotherapy are treated using uniform dose constraints specific to the tumor and surrounding normal tissues. This is suboptimal in many ways. First, the dose that can be delivered to the target volume may be insufficient for control but is constrained by the surrounding normal tissue, as dose escalation can lead to significant morbidity and rare. Second, two patients with nearly identical dose distributions can have substantially different acute and late toxicities, resulting in lengthy treatment breaks and suboptimal control, or chronic morbidities leading to poor quality of life. Despite significant advances in radiogenomics, the magnitude of the genetic contribution to radiation response far exceeds our current understanding of individual risk variants. In the field of genomics, ML methods are being used to extract harder-to-detect knowledge, but these methods have yet to fully penetrate radiogenomics. Hence, the goal of this publication is to provide an overview of ML as it applies to radiogenomics. We begin with a brief history of radiogenomics and its relationship to precision medicine. We then introduce ML and compare it to statistical hypothesis testing to reflect on shared lessons and to avoid common pitfalls. Current ML approaches to genome-wide association studies are examined. The application of ML specifically to radiogenomics is next presented. We end with important lessons for the proper integration of ML into radiogenomics. |
format | Online Article Text |
id | pubmed-6021505 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-60215052018-07-05 Machine Learning and Radiogenomics: Lessons Learned and Future Directions Kang, John Rancati, Tiziana Lee, Sangkyu Oh, Jung Hun Kerns, Sarah L. Scott, Jacob G. Schwartz, Russell Kim, Seyoung Rosenstein, Barry S. Front Oncol Oncology Due to the rapid increase in the availability of patient data, there is significant interest in precision medicine that could facilitate the development of a personalized treatment plan for each patient on an individual basis. Radiation oncology is particularly suited for predictive machine learning (ML) models due to the enormous amount of diagnostic data used as input and therapeutic data generated as output. An emerging field in precision radiation oncology that can take advantage of ML approaches is radiogenomics, which is the study of the impact of genomic variations on the sensitivity of normal and tumor tissue to radiation. Currently, patients undergoing radiotherapy are treated using uniform dose constraints specific to the tumor and surrounding normal tissues. This is suboptimal in many ways. First, the dose that can be delivered to the target volume may be insufficient for control but is constrained by the surrounding normal tissue, as dose escalation can lead to significant morbidity and rare. Second, two patients with nearly identical dose distributions can have substantially different acute and late toxicities, resulting in lengthy treatment breaks and suboptimal control, or chronic morbidities leading to poor quality of life. Despite significant advances in radiogenomics, the magnitude of the genetic contribution to radiation response far exceeds our current understanding of individual risk variants. In the field of genomics, ML methods are being used to extract harder-to-detect knowledge, but these methods have yet to fully penetrate radiogenomics. Hence, the goal of this publication is to provide an overview of ML as it applies to radiogenomics. We begin with a brief history of radiogenomics and its relationship to precision medicine. We then introduce ML and compare it to statistical hypothesis testing to reflect on shared lessons and to avoid common pitfalls. Current ML approaches to genome-wide association studies are examined. The application of ML specifically to radiogenomics is next presented. We end with important lessons for the proper integration of ML into radiogenomics. Frontiers Media S.A. 2018-06-21 /pmc/articles/PMC6021505/ /pubmed/29977864 http://dx.doi.org/10.3389/fonc.2018.00228 Text en Copyright © 2018 Kang, Rancati, Lee, Oh, Kerns, Scott, Schwartz, Kim and Rosenstein. https://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Oncology Kang, John Rancati, Tiziana Lee, Sangkyu Oh, Jung Hun Kerns, Sarah L. Scott, Jacob G. Schwartz, Russell Kim, Seyoung Rosenstein, Barry S. Machine Learning and Radiogenomics: Lessons Learned and Future Directions |
title | Machine Learning and Radiogenomics: Lessons Learned and Future Directions |
title_full | Machine Learning and Radiogenomics: Lessons Learned and Future Directions |
title_fullStr | Machine Learning and Radiogenomics: Lessons Learned and Future Directions |
title_full_unstemmed | Machine Learning and Radiogenomics: Lessons Learned and Future Directions |
title_short | Machine Learning and Radiogenomics: Lessons Learned and Future Directions |
title_sort | machine learning and radiogenomics: lessons learned and future directions |
topic | Oncology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6021505/ https://www.ncbi.nlm.nih.gov/pubmed/29977864 http://dx.doi.org/10.3389/fonc.2018.00228 |
work_keys_str_mv | AT kangjohn machinelearningandradiogenomicslessonslearnedandfuturedirections AT rancatitiziana machinelearningandradiogenomicslessonslearnedandfuturedirections AT leesangkyu machinelearningandradiogenomicslessonslearnedandfuturedirections AT ohjunghun machinelearningandradiogenomicslessonslearnedandfuturedirections AT kernssarahl machinelearningandradiogenomicslessonslearnedandfuturedirections AT scottjacobg machinelearningandradiogenomicslessonslearnedandfuturedirections AT schwartzrussell machinelearningandradiogenomicslessonslearnedandfuturedirections AT kimseyoung machinelearningandradiogenomicslessonslearnedandfuturedirections AT rosensteinbarrys machinelearningandradiogenomicslessonslearnedandfuturedirections |